Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Head and Neck Cancer

  Free Subscription


01.01.2020

1 Am J Gastroenterol
4 Ann Otol Rhinol Laryngol
8 Ann Thorac Surg
5 Anticancer Res
11 BMC Cancer
3 Br J Cancer
11 Br J Oral Maxillofac Surg
1 Cancer
2 Cancer Res
2 Clin Cancer Res
1 Clin Nucl Med
3 Dis Esophagus
1 Gastrointest Endosc
8 Head Neck
3 HNO
6 Int J Cancer
1 Int J Pediatr Otorhinolaryngol
4 Int J Radiat Oncol Biol Phys
2 J Clin Endocrinol Metab
1 J Clin Oncol
1 Laryngoscope
3 Ophthalmic Plast Reconstr Surg
14 Oral Oncol
1 PLoS Comput Biol
1 PLoS Genet
7 PLoS One
2 Radiology
5 Radiother Oncol
4 Surgery
8 Thyroid


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Gastroenterol

  1. TORRES HA, Economides MP, Angelidakis G, Hosry J, et al
    Sofosbuvir-Based Therapy in Hepatitis C Virus-infected Cancer Patients: A Prospective Observational Study.
    Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0383.
    PubMed     Text format     Abstract available


    Ann Otol Rhinol Laryngol

  2. LIU C, Tang L, Goel P, Chambers T, et al
    A Practical Mathematic Method to Predict and Manage Hypocalcemia After Parathyroidectomy and Thyroidectomy.
    Ann Otol Rhinol Laryngol. 2020;129:70-77.
    PubMed     Text format     Abstract available

  3. CHOI JS, Sansoni ER, Lovin BD, Lindquist NR, et al
    Abscopal Effect Following Immunotherapy and Combined Stereotactic Body Radiation Therapy in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma: A Report of Two Cases and Literature Review.
    Ann Otol Rhinol Laryngol. 2019 Dec 25:3489419896602.
    PubMed     Text format     Abstract available

  4. YAN K, Taxy JB, Paintal A, Friedman AD, et al
    Atypical Laryngeal Infections: Localized Lesions from Unusual Organisms May Simulate Malignancy.
    Ann Otol Rhinol Laryngol. 2020;129:82-86.
    PubMed     Text format     Abstract available

  5. ZHU A, Mohan S, Richmon JD, Jowett N, et al
    An Anatomic Variant of the Ansa Cervicalis Precluding Its Use as a Donor Nerve.
    Ann Otol Rhinol Laryngol. 2020;129:78-81.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  6. CARROLL PA, Kinsella A, Darling G, Ouzounian M, et al
    Transdiaphragmatic Gastroventricular Fistula.
    Ann Thorac Surg. 2019;107:e329-e331.
    PubMed     Text format     Abstract available

  7. LEE F, Yu W, Loor G, Burt BM, et al
    Approach to a Posterior Cervicomediastinal Ganglioneuroma.
    Ann Thorac Surg. 2019;107:e349-e351.
    PubMed     Text format     Abstract available

  8. MALLER B, Kaszuba F, Tanvetyanon T
    Complete Tumor Response of Tracheal Squamous Cell Carcinoma After Treatment With Pembrolizumab.
    Ann Thorac Surg. 2019;107:e273-e274.
    PubMed     Text format     Abstract available

  9. HORNE ZD, Wegner RE, Colonias A, Weksler B, et al
    Drivers of 30-/90-day post-op mortality following neoadjuvant chemoradiation for esophageal cancer.
    Ann Thorac Surg. 2019 Dec 14. pii: S0003-4975(19)31871.
    PubMed     Text format     Abstract available

  10. BANASZEWSKI J, Gaggl A, Buerger H, Wierzbicka M, et al
    One-Step Laryngotracheal Reconstruction With Prefabricated Corticoperiosteal Flap.
    Ann Thorac Surg. 2019;107:e333-e335.
    PubMed     Text format     Abstract available

  11. BISWAS ROY S, Banks P, Kunz M, Ipsen TR, et al
    Prevalence and Natural History of Barrett's Esophagus in Lung Transplant: A Single-Center Experience.
    Ann Thorac Surg. 2019;107:1017-1023.
    PubMed     Text format     Abstract available

  12. DU ZS, Li XY, Luo HS, Wu SX, et al
    Preoperative Administration of Olive Oil Reduces Chylothorax after Minimally Invasive Esophagectomy.
    Ann Thorac Surg. 2018 Nov 30. pii: S0003-4975(18)31713.
    PubMed     Text format     Abstract available

  13. GOROSPE L, Garcia-Gomez-Muriel I, Pian-Arias HG, Gomez-Ramirez J, et al
    Development of thyroid carcinoma during treatment with pembrolizumab in a lung cancer patient.
    Ann Thorac Surg. 2019 Dec 14. pii: S0003-4975(19)31873.
    PubMed     Text format     Abstract available


    Anticancer Res

  14. SOHN M, Agha A, Trum S, Moser C, et al
    Frequency of Polyps and Adenocarcinoma in Colon Interposition After Esophagectomy in Adulthood - A Systematic Review.
    Anticancer Res. 2019;39:6419-6430.
    PubMed     Text format     Abstract available

  15. NAKAMURA J, Furuya S, Hagio K, Maruyama S, et al
    Differential miRNA Expression in Basaloid Squamous Cell Carcinoma of the Oesophagus: miR-3687 Targets PGRMC2.
    Anticancer Res. 2019;39:6471-6478.
    PubMed     Text format     Abstract available

  16. NAGAI J, Shi H, Sezaki N, Yoshida N, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Arylazolylchromones and 2-Triazolylchromones.
    Anticancer Res. 2019;39:6479-6488.
    PubMed     Text format     Abstract available

  17. UESAWA Y, Nagai J, Shi H, Sakagami H, et al
    Quantitative Structure-Cytotoxicity Relationship of 2-Styrylchromones.
    Anticancer Res. 2019;39:6489-6498.
    PubMed     Text format     Abstract available

  18. IIJIMA Y, Bandow K, Sano M, Hino S, et al
    In Vitro Assessment of Antitumor Potential and Combination Effect of Classical and Molecular-targeted Anticancer Drugs.
    Anticancer Res. 2019;39:6673-6684.
    PubMed     Text format     Abstract available


    BMC Cancer

  19. XU M, Wang X, Pan Y, Zhao X, et al
    Blocking podoplanin suppresses growth and pulmonary metastasis of human malignant melanoma.
    BMC Cancer. 2019;19:599.
    PubMed     Text format     Abstract available

  20. WAGNER AD, Grabsch HI, Mauer M, Marreaud S, et al
    EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction
    BMC Cancer. 2019;19:494.
    PubMed     Text format     Abstract available

  21. LEKOANE KMB, Kuupiel D, Mashamba-Thompson TP, Ginindza TG, et al
    Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    BMC Cancer. 2019;19:563.
    PubMed     Text format     Abstract available

  22. ZHOU Y, Sinha S, Schwartz JL, Adami GR, et al
    A subtype of oral, laryngeal, esophageal, and lung, squamous cell carcinoma with high levels of TrkB-T1 neurotrophin receptor mRNA.
    BMC Cancer. 2019;19:607.
    PubMed     Text format     Abstract available

  23. VAN GYSEN K, Stevens M, Guo L, Jayamanne D, et al
    Validation of the 8(th) edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy.
    BMC Cancer. 2019;19:674.
    PubMed     Text format     Abstract available

  24. GUINAN EM, Bennett AE, Doyle SL, O'Neill L, et al
    Measuring the impact of oesophagectomy on physical functioning and physical activity participation: a prospective study.
    BMC Cancer. 2019;19:682.
    PubMed     Text format     Abstract available

  25. LIU X, Jin J, Cai H, Huang H, et al
    Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    BMC Cancer. 2019;19:606.
    PubMed     Text format     Abstract available

  26. FANG Q, Wu J, Du W, Zhang X, et al
    Predictors of distant metastasis in parotid acinic cell carcinoma.
    BMC Cancer. 2019;19:475.
    PubMed     Text format     Abstract available

  27. XUE KS, Tang L, Sun G, Wang S, et al
    Mycotoxin exposure is associated with increased risk of esophageal squamous cell carcinoma in Huaian area, China.
    BMC Cancer. 2019;19:1218.
    PubMed     Text format     Abstract available

  28. ZAPATA I, Alvarez M, Hidalgo R, Pajares B, et al
    Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy.
    BMC Cancer. 2019;19:1241.
    PubMed     Text format     Abstract available

  29. HAGENS ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, et al
    Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.
    BMC Cancer. 2019;19:662.
    PubMed     Text format     Abstract available


    Br J Cancer

  30. HADLER-OLSEN E, Wirsing AM
    Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Br J Cancer. 2019;120:714-727.
    PubMed     Text format     Abstract available

  31. SHEN B, Huang D, Ramsey AJ, Ig-Izevbekhai K, et al
    PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma.
    Br J Cancer. 2019 Dec 19. pii: 10.1038/s41416-019-0697.
    PubMed     Text format     Abstract available

  32. ZHANG W, Cheng J, Diao P, Wang D, et al
    Therapeutically targeting head and neck squamous cell carcinoma through synergistic inhibition of LSD1 and JMJD3 by TCP and GSK-J1.
    Br J Cancer. 2019 Dec 18. pii: 10.1038/s41416-019-0680.
    PubMed     Text format     Abstract available


    Br J Oral Maxillofac Surg

  33. MCALLISTER P, O'Neill T, Devlin M
    Congenital epulis: a rare case of feeding obstruction in a neonate.
    Br J Oral Maxillofac Surg. 2019;57:484-486.
    PubMed     Text format    

  34. HUSTON M, Merrick G, Al-Rikabi A
    Postoperative neck pain associated with an implantable microvascular ultrasonic Doppler: a case report.
    Br J Oral Maxillofac Surg. 2019;57:265-267.
    PubMed     Text format     Abstract available

  35. ROGERS SN, Travers A, Lowe D, Levy AR, et al
    Importance of activity and recreation for the quality of life of patients treated for cancer of the head and neck.
    Br J Oral Maxillofac Surg. 2019;57:125-134.
    PubMed     Text format     Abstract available

  36. MASCHIO F, Lejuste P, Ilankovan V
    Evolution in the management of oropharyngeal squamous cell carcinoma: systematic review of outcomes over the last 25 years.
    Br J Oral Maxillofac Surg. 2019;57:101-115.
    PubMed     Text format     Abstract available

  37. ROGERS SN, Staunton A, Girach R, Langton S, et al
    Audit of the two-week pathway for patients with suspected cancer of the head and neck and the influence of socioeconomic status.
    Br J Oral Maxillofac Surg. 2019;57:419-424.
    PubMed     Text format     Abstract available

  38. KOLATOR M, Mikula B, Maciejczyk A, Zatonski T, et al
    Polish validation of the University of Washington "quality of life" questionnaire in patients with cancer of the larynx.
    Br J Oral Maxillofac Surg. 2019;57:226-231.
    PubMed     Text format     Abstract available

  39. DOUMAS S, Fort-Schaale A, Skoulakis C, Moor J, et al
    Current thinking on the management of abnormal retropharyngeal nodes in patients with oral, oropharyngeal, and nasopharyngeal squamous cell carcinoma: a structured review.
    Br J Oral Maxillofac Surg. 2019;57:515-528.
    PubMed     Text format     Abstract available

  40. GUO Z, Zhang J, Gong Z, Jing S, et al
    Correlation of factors associated with postoperative infection in patients with malignant oral and maxillofacial tumours: a logistic regression analysis.
    Br J Oral Maxillofac Surg. 2019;57:460-465.
    PubMed     Text format     Abstract available

  41. MANTSOPOULOS K, Goncalves M, Koch M, Iro H, et al
    Watchful waiting in carefully selected metachronous cystadenolymphomas of the parotid gland: a reliable option?
    Br J Oral Maxillofac Surg. 2019;57:425-429.
    PubMed     Text format     Abstract available

  42. RAJAPPA SK, Ram D, Shukla H, Mandal G, et al
    Oncological benefits of postoperative radiotherapy in node-negative early stage cancer of the oral cavity with isolated perineural invasion.
    Br J Oral Maxillofac Surg. 2019;57:454-459.
    PubMed     Text format     Abstract available

  43. MIN HJ, Suh KD, Lee YH, Kim KS, et al
    Cytoplasmic HMGB1 and HMGB1-Beclin1 complex are increased in radioresistant oral squamous cell carcinoma.
    Br J Oral Maxillofac Surg. 2019;57:219-225.
    PubMed     Text format     Abstract available


    Cancer

  44. DZIEGIELEWSKI PT, McNeely ML, Ashworth N, O'Connell DA, et al
    2b or not 2b? Shoulder function after level 2b neck dissection: A double-blind randomized controlled clinical trial.
    Cancer. 2019 Dec 24. doi: 10.1002/cncr.32681.
    PubMed     Text format     Abstract available


    Cancer Res

  45. MIYAUCHI S, Sanders PD, Guram K, Kim SS, et al
    HPV16 E5 Mediates Resistance to PD-L1 Blockade and can be targeted with Rimantadine in Head and Neck Cancer.
    Cancer Res. 2019 Dec 17. pii: 0008-5472.CAN-19-1771.
    PubMed     Text format     Abstract available

  46. FAN S, Tian T, Chen W, Lv X, et al
    Mitochondrial miRNA Determines Chemoresistance by Reprogramming Metabolism and Regulating Mitochondrial Transcription.
    Cancer Res. 2019;79:1069-1084.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  47. DE LA IGLESIA JV, Slebos RJ, Martin-Gomez L, Wang X, et al
    Effects of tobacco smoking on the tumor immune microenvironment in head and neck squamous cell carcinoma.
    Clin Cancer Res. 2019 Dec 17. pii: 1078-0432.CCR-19-1769.
    PubMed     Text format     Abstract available

  48. GREENE S, Robbins Y, Mydlarz WK, Huynh AP, et al
    Inhibition of MDSC trafficking with SX-682, a CXCR1/2 inhibitor, enhances NK cell immunotherapy in head and neck cancer models.
    Clin Cancer Res. 2019 Dec 17. pii: 1078-0432.CCR-19-2625.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  49. PAEPEGAEY AC, Velayoudom FL, Housni S, Gauthe M, et al
    A Hungry Bone Syndrome Predicted by 18F-Fluorocholine PET/CT.
    Clin Nucl Med. 2019 Jul 2. doi: 10.1097/RLU.0000000000002676.
    PubMed     Text format     Abstract available


    Dis Esophagus

  50. LI L, Linghu E, Chai N, Li Z, et al
    Efficacy of triamcinolone-soaked polyglycolic acid sheet plus fully covered metal stent for preventing stricture formation after large esophageal endoscopic submucosal dissection.
    Dis Esophagus. 2019;32.
    PubMed     Text format     Abstract available

  51. DENG HY, Hou L, Zha P
    Sarcopenia: an unneglectable nutritional status in oncological esophagectomy.
    Dis Esophagus. 2019;32.
    PubMed     Text format    

  52. MAO YS, Gao SG, Wang Q, Shi XT, et al
    Analysis of a registry database for esophageal cancer from high-volume centers in China.
    Dis Esophagus. 2019 Dec 20. pii: 5681793. doi: 10.1093.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  53. THAKKAR SJ, Kochhar GS
    Artificial intelligence for real-time detection of early esophageal cancer: another set of eyes to better visualize.
    Gastrointest Endosc. 2020;91:52-54.
    PubMed     Text format    


    Head Neck

  54. MAKITIE AA, Almangush A, Youssef O, Metsala M, et al
    Exhaled breath analysis in the diagnosis of head and neck cancer.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26043.
    PubMed     Text format     Abstract available

  55. LEE YH, Goo-Yoshino S, Lew HL, Chi WC, et al
    Social participation in head and neck cancer survivors with swallowing disorder: World Health Organization Disability Assessment Schedule 2.0 study.
    Head Neck. 2019 Dec 30. doi: 10.1002/hed.26062.
    PubMed     Text format     Abstract available

  56. CHEN Q, Zou X, Ma Y, Liu F, et al
    Pseudomonas aeruginosa-mannose sensitive hemagglutinin injection therapy for the treatment of chyle fistula following neck dissection.
    Head Neck. 2019 Dec 28. doi: 10.1002/hed.26054.
    PubMed     Text format     Abstract available

  57. TIAN S, Switchenko JM, Fei T, Press RH, et al
    Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
    Head Neck. 2019 Dec 16. doi: 10.1002/hed.26042.
    PubMed     Text format     Abstract available

  58. SAITO Y, Favorov AV, Forman M, Ren S, et al
    Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.
    Head Neck. 2019 Dec 18. doi: 10.1002/hed.26041.
    PubMed     Text format     Abstract available

  59. MEHDIZADEH OB, Dhar SI, Evangelista L, Nativ-Zeltzer N, et al
    Prevalence of profound laryngeal sensory neuropathy in head and neck cancer survivors with feeding tube-dependent oropharyngeal dysphagia.
    Head Neck. 2019 Dec 27. doi: 10.1002/hed.26059.
    PubMed     Text format     Abstract available

  60. RUEGG P, Morand GB, Kudura K, Rupp NJ, et al
    Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax , p16-negativity, and low nodal shrinkage.
    Head Neck. 2019 Dec 19. doi: 10.1002/hed.26045.
    PubMed     Text format     Abstract available

  61. SUN C, Wang Q, Guo Q, Chang Q, et al
    Analysis of patterns and risk factors regarding the onset of nodules in the contralateral thyroid lobe during follow-up ultrasonography among patients after unilateral lobectomy for the treatment of papillary thyroid carcinoma.
    Head Neck. 2019 Dec 24. doi: 10.1002/hed.26056.
    PubMed     Text format     Abstract available


    HNO

  62. MOCKELMANN N, Betz C
    [New aspects in thyroid cancer treatment : Highlights of the 2019 ASCO Annual Meeting].
    HNO. 2019;67:925-930.
    PubMed     Text format     Abstract available

  63. DOESCHER J, Schuler PJ, Greve J, Meyer MF, et al
    [Salivary gland malignancies-highlights of the 2019 ASCO Annual Meeting].
    HNO. 2019;67:931-934.
    PubMed     Text format     Abstract available

  64. VAHL JM, Schuler PJ, Greve J, Laban S, et al
    [Laryngectomy-still state of the art?]
    HNO. 2019;67:955-976.
    PubMed     Text format     Abstract available


    Int J Cancer

  65. PALACIOS-GARCIA J, Sanz-Flores M, Asensio A, Alvarado R, et al
    G-protein coupled receptor kinase 2 safeguards epithelial phenotype in Head and Neck Squamous Cell Carcinomas.
    Int J Cancer. 2019 Dec 18. doi: 10.1002/ijc.32838.
    PubMed     Text format     Abstract available

  66. SU TH, Tseng TC, Liu CJ, Chou SW, et al
    Antiviral Therapy against Chronic Hepatitis C is Associated with a Reduced Risk of Oral Cancer.
    Int J Cancer. 2019 Dec 19. doi: 10.1002/ijc.32840.
    PubMed     Text format     Abstract available

  67. GANLY I, Yang L, Giese RA, Hao Y, et al
    Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus.
    Int J Cancer. 2019;145:775-784.
    PubMed     Text format     Abstract available

  68. ISLAMI F, Kamangar F, Malekzadeh R
    Reply to Comment on "A prospective study of tea drinking temperature.. " by Islami et al.
    Int J Cancer. 2019;145:1446-1447.
    PubMed     Text format    

  69. RANJAN D
    Comment on "A Prospective Study of Tea Drinking Temperature.." by Islami et al.
    Int J Cancer. 2019;145:1445.
    PubMed     Text format    

  70. WILKAT M, Bast H, Drees R, Dunser J, et al
    Adenosine receptor 2B activity promotes autonomous growth, migration as well as vascularization of head and neck squamous cell carcinoma cells.
    Int J Cancer. 2019 Dec 17. doi: 10.1002/ijc.32835.
    PubMed     Text format     Abstract available


    Int J Pediatr Otorhinolaryngol

  71. SETHIA R, Rawlins KW, Aljasser A, Nogan S, et al
    Pediatric nasopharyngeal fibrolipoma: A case report and review of the literature.
    Int J Pediatr Otorhinolaryngol. 2019;125:103-106.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  72. NING MS, Gomez DR, Shah AK, Kim CR, et al
    The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care.
    Int J Radiat Oncol Biol Phys. 2019;104:724-733.
    PubMed     Text format     Abstract available

  73. WU J, Gensheimer MF, Zhang N, Han F, et al
    Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;104:942-952.
    PubMed     Text format     Abstract available

  74. ANDERSON CM, Kimple RJ, Lin A, Karam SD, et al
    De-Escalation Strategies in HPV-Associated Oropharynx Cancer-Are we Putting the Cart Before the Horse?
    Int J Radiat Oncol Biol Phys. 2019;104:705-709.
    PubMed     Text format    

  75. GENSHEIMER MF, Le QT
    Radiographic Extranodal Extension in Human Papillomavirus-Associated Oropharyngeal Carcinoma: Can it Help Tailor Treatment?
    Int J Radiat Oncol Biol Phys. 2019;104:1028-1029.
    PubMed     Text format    


    J Clin Endocrinol Metab

  76. HAYMART MR, Banerjee M, Reyes-Gastelum D, Caoili E, et al
    Thyroid Ultrasound and the Increase in Diagnosis of Low-risk Thyroid Cancer.
    J Clin Endocrinol Metab. 2018 Oct 16. pii: 5128913. doi: 10.1210/jc.2018-01933.
    PubMed     Text format     Abstract available

  77. COLOMBO C, De Leo S, Di Stefano M, Vannucchi G, et al
    Primary Adrenal Insufficiency During Lenvatinib or Vandetanib and Improvement of Fatigue After Cortisone Acetate Therapy.
    J Clin Endocrinol Metab. 2019;104:779-784.
    PubMed     Text format     Abstract available


    J Clin Oncol

  78. AMIT M, Abdelmeguid AS, Watcherporn T, Takahashi H, et al
    Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
    J Clin Oncol. 2019;37:504-512.
    PubMed     Text format     Abstract available


    Laryngoscope

  79. KILIC A, Barlak N, Sanli F, Aytatli A, et al
    Mode of action of carboplatin via activating p53/miR-145 axis in head and neck cancers.
    Laryngoscope. 2019 Dec 30. doi: 10.1002/lary.28492.
    PubMed     Text format     Abstract available


    Ophthalmic Plast Reconstr Surg

  80. PURGERT RJ, Blandford AD, Schowalter MK, Piliang MP, et al
    Collagenoma of the Eyelid.
    Ophthalmic Plast Reconstr Surg. 2019 Jan 7. doi: 10.1097/IOP.0000000000001298.
    PubMed     Text format     Abstract available

  81. MAENG MM, Godfrey KJ, Kazim M
    Preseptal Upper Eyelid Lipoma.
    Ophthalmic Plast Reconstr Surg. 2018 Nov 9. doi: 10.1097/IOP.0000000000001268.
    PubMed     Text format     Abstract available

  82. AKELLA SS, Lee T, Barmettler A
    Lichenoid Dermatitis Development After Excision of Basal Cell Carcinoma.
    Ophthalmic Plast Reconstr Surg. 2019;35:e34-e36.
    PubMed     Text format     Abstract available


    Oral Oncol

  83. SINHA P, Karadaghy OA, Doering MM, Tuuli MG, et al
    Survival for HPV-positive oropharyngeal squamous cell carcinoma with surgical versus non-surgical treatment approach: A systematic review and meta-analysis.
    Oral Oncol. 2018;86:121-131.
    PubMed     Text format     Abstract available

  84. HUANG SH, Hahn E, Tsang RK, Chen ZJ, et al
    The interplay of IMRT and transoral surgery in HPV-mediated oropharyngeal cancer: Getting the balance right.
    Oral Oncol. 2018;86:171-180.
    PubMed     Text format     Abstract available

  85. CANNON RB, Houlton JJ, Patel S, Raju S, et al
    Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Oral Oncol. 2018;86:296-300.
    PubMed     Text format     Abstract available

  86. SATHASIVAM HP, Bhatia R, Bradley P, Robson A, et al
    Concurrent HPV-related oropharyngeal carcinoma in four couples.
    Oral Oncol. 2018;86:33-37.
    PubMed     Text format     Abstract available

  87. PIKE LRG, Hwang WL, Royce TJ, Sanford NN, et al
    HPV status predicts for improved survival following chemotherapy in metastatic squamous cell carcinoma of the oropharynx.
    Oral Oncol. 2018;86:69-74.
    PubMed     Text format     Abstract available

  88. ANSARI E, Chargi N, van Gemert JTM, van Es RJJ, et al
    Low skeletal muscle mass is a strong predictive factor for surgical complications and a prognostic factor in oral cancer patients undergoing mandibular reconstruction with a free fibula flap.
    Oral Oncol. 2019;101:104530.
    PubMed     Text format     Abstract available

  89. JAYARAJ R, Kumarasamy C, Sabarimurugan S, Madhav MR, et al
    Prognostic significance of Lymph Node Ratio (LNR): Clinical insights and strategies for routine clinical practice.
    Oral Oncol. 2019;91:125-127.
    PubMed     Text format    

  90. JAYARAJ R, Kumarasamy C, Royam MM, Sabarimurugan S, et al
    Prognostic implications of pathologic lymph nodes in HPV-positive oropharyngeal cancers: Clinical validity and strategies for routine clinical practice.
    Oral Oncol. 2019 Mar 8. pii: S1368-8375(19)30074.
    PubMed     Text format    

  91. AANYA A, Hegde PS, Fernando CA, Thakur S, et al
    Intolerance to pungent spices among patients receiving radiation and chemotherapy for head and neck cancers.
    Oral Oncol. 2019 Dec 16:104517. doi: 10.1016/j.oraloncology.2019.104517.
    PubMed     Text format    

  92. AMPIL F, Previgliano C, Porter C, Richards T, et al
    Metachronous mediastinal and lung metastases from head and neck cancer: A case series, literature review and considerations for treatment.
    Oral Oncol. 2019 Dec 17:104518. doi: 10.1016/j.oraloncology.2019.104518.
    PubMed     Text format     Abstract available

  93. MATSUO M, Yasumatsu R, Masuda M, Toh S, et al
    Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab.
    Oral Oncol. 2019;101:104525.
    PubMed     Text format     Abstract available

  94. PESTANA RC, Becnel M, Rubin ML, Torman DK, et al
    Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma.
    Oral Oncol. 2019;101:104523.
    PubMed     Text format     Abstract available

  95. BLACK M, Ghasemi F, Sun RX, Stecho W, et al
    Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.
    Oral Oncol. 2019;101:104529.
    PubMed     Text format     Abstract available

  96. BEELER WH, Bellile EL, Casper KA, Jaworski E, et al
    Patient-reported financial toxicity and adverse medical consequences in head and neck cancer.
    Oral Oncol. 2019;101:104521.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  97. CHEN X, Zhu CC, Yin J
    Ensemble of decision tree reveals potential miRNA-disease associations.
    PLoS Comput Biol. 2019;15:e1007209.
    PubMed     Text format     Abstract available


    PLoS Genet

  98. GLUCK C, Glathar A, Tsompana M, Nowak N, et al
    Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma.
    PLoS Genet. 2019;15:e1008250.
    PubMed     Text format     Abstract available


    PLoS One

  99. KIM DK, Kim EK, Jung DW, Kim J, et al
    Cytoskeletal alteration modulates cancer cell invasion through RhoA-YAP signaling in stromal fibroblasts.
    PLoS One. 2019;14:e0214553.
    PubMed     Text format     Abstract available

  100. KROENKE M, Hirata K, Gafita A, Watanabe S, et al
    Voxel based comparison and texture analysis of 18F-FDG and 18F-FMISO PET of patients with head-and-neck cancer.
    PLoS One. 2019;14:e0213111.
    PubMed     Text format     Abstract available

  101. GUEZENNEC C, Bourhis D, Orlhac F, Robin P, et al
    Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.
    PLoS One. 2019;14:e0214299.
    PubMed     Text format     Abstract available

  102. HSING EW, Shiah SG, Peng HY, Chen YW, et al
    TNF-alpha-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility.
    PLoS One. 2019;14:e0213463.
    PubMed     Text format     Abstract available

  103. MACEDO LT, Ferrari VE, Carron J, Costa EFD, et al
    Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach.
    PLoS One. 2019;14:e0213929.
    PubMed     Text format     Abstract available

  104. GRISANTI S, Bianchi S, Locati LD, Triggiani L, et al
    Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events.
    PLoS One. 2019;14:e0213934.
    PubMed     Text format     Abstract available

  105. NEMETH CG, Rocken C, Siebert R, Wiltfang J, et al
    Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus.
    PLoS One. 2019;14:e0215055.
    PubMed     Text format     Abstract available


    Radiology

  106. HA SM, Baek JH, Na DG, Suh CH, et al
    Diagnostic Performance of Practice Guidelines for Thyroid Nodules: Thyroid Nodule Size versus Biopsy Rates.
    Radiology. 2019;291:92-99.
    PubMed     Text format     Abstract available

  107. SERRANO LF, Valencia S
    The Cracking Thyroid.
    Radiology. 2019;291:14.
    PubMed     Text format    


    Radiother Oncol

  108. BRUIJNEN T, Stemkens B, Terhaard CHJ, Lagendijk JJW, et al
    Intrafraction motion quantification and planning target volume margin determination of head-and-neck tumors using cine magnetic resonance imaging.
    Radiother Oncol. 2019;130:82-88.
    PubMed     Text format     Abstract available

  109. VAARWERK B, Hol MLF, Schoot RA, Breunis WB, et al
    AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
    Radiother Oncol. 2019;131:21-26.
    PubMed     Text format     Abstract available

  110. TOL JP, Dahele M, Gregoire V, Overgaard J, et al
    Analysis of EORTC-1219-DAHANCA-29 trial plans demonstrates the potential of knowledge-based planning to provide patient-specific treatment plan quality assurance.
    Radiother Oncol. 2019;130:75-81.
    PubMed     Text format     Abstract available

  111. BANDURSKA-LUQUE A, Lock S, Haase R, Richter C, et al
    FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients.
    Radiother Oncol. 2019;130:97-103.
    PubMed     Text format     Abstract available

  112. DUTZ A, Lock S
    Competing risks in survival data analysis.
    Radiother Oncol. 2019;130:185-189.
    PubMed     Text format     Abstract available


    Surgery

  113. SHAHA AR, Tuttle RM
    Commentary on "Incidence of total thyroidectomy and lobectomy".
    Surgery. 2019 Mar 20. pii: S0039-6060(19)30060.
    PubMed     Text format    

  114. LAKIS ME, Kebebew E
    Reply: Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.
    Surgery. 2019 Mar 22. pii: S0039-6060(19)30068.
    PubMed     Text format    

  115. BENBASSAT C
    Familial nonmedullary thyroid cancer: When the data and conclusions do not match.
    Surgery. 2018 Dec 6. pii: S0039-6060(18)30778-5. doi: 10.1016/j.surg.2018.
    PubMed     Text format    

  116. ZHANG HS, Lee EK, Jung YS, Nam BH, et al
    Total thyroidectomy's association with survival in papillary thyroid cancers and the high proportion of total thyroidectomy in low-risk patients: Analysis of Korean nationwide data.
    Surgery. 2018 Oct 17. pii: S0039-6060(18)30636.
    PubMed     Text format     Abstract available


    Thyroid

  117. SONG E, Ahn J, Jeon M, Lee SM, et al
    Estimating the growth rate of lung metastases in differentiated thyroid carcinoma: Response Evaluation Criteria in Solid Tumors or doubling time?
    Thyroid. 2019 Dec 27. doi: 10.1089/thy.2019.0341.
    PubMed     Text format     Abstract available

  118. DEKKER B, van der Horst-Schrivers ANA, Sluiter WJ, Brouwers AH, et al
    The clinical applicability of low levels of thyroglobulin autoantibodies (TgAbs) as cut-off point for TgAb positivity.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2018.0195.
    PubMed     Text format     Abstract available

  119. LI P, Zhang A, Liu Y, Xu C, et al
    131I Therapy in Patients with Differentiated Thyroid Cancer: Study of External Dose Rate Attenuation Law and Individualized Patient Management.
    Thyroid. 2018 Oct 23. doi: 10.1089/thy.2017.0570.
    PubMed     Text format     Abstract available

  120. BOUFRAQECH M, Patel D, Nilubol N, Powers AS, et al
    Lysyl Oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness.
    Thyroid. 2018 Nov 6. doi: 10.1089/thy.2018.0424.
    PubMed     Text format     Abstract available

  121. SIGAL GA, Tavoni T, Silva B, Kalil Filho R, et al
    Effects of short term hypothyroidism on the lipid transfer to HDL and other parameters related to lipoprotein metabolism in patients submitted to thyroidectomy for thyroid cancer.
    Thyroid. 2018 Nov 9. doi: 10.1089/thy.2018.0190.
    PubMed     Text format     Abstract available

  122. LUSTER M, Aktolun C, Amendoeira I, Barczynski M, et al
    European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Proceedings of an interactive international symposium.
    Thyroid. 2018 Nov 28. doi: 10.1089/thy.2017.0129.
    PubMed     Text format     Abstract available

  123. JIN Y, Ruan M, Cheng L, Fu H, et al
    Radioiodine Uptake and Thyroglobulin Guided Radioiodine Remnant Ablation in Patients with Differentiated Thyroid Cancer: A Prospective, Randomized, Open-label, Controlled Trial.
    Thyroid. 2018 Dec 18. doi: 10.1089/thy.2018.0028.
    PubMed     Text format     Abstract available

  124. SHEN M, Wang C, Li Z
    Letter to the Editor regarding the article "Impact of extranodal extension on risk stratification in papillary thyroid carcinoma".
    Thyroid. 2019 Dec 17. doi: 10.1089/thy.2019.0287.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: